DUOCAINE Drug Patent Profile
✉ Email this page to a colleague
When do Duocaine patents expire, and when can generic versions of Duocaine launch?
Duocaine is a drug marketed by Amphastar Pharms Inc and is included in one NDA.
The generic ingredient in DUOCAINE is bupivacaine hydrochloride; lidocaine hydrochloride. There are twelve drug master file entries for this compound. Additional details are available on the bupivacaine hydrochloride; lidocaine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DUOCAINE?
- What are the global sales for DUOCAINE?
- What is Average Wholesale Price for DUOCAINE?
Summary for DUOCAINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| DailyMed Link: | DUOCAINE at DailyMed |
US Patents and Regulatory Information for DUOCAINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amphastar Pharms Inc | DUOCAINE | bupivacaine hydrochloride; lidocaine hydrochloride | INJECTABLE;INJECTION | 021496-001 | May 23, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
